BACKGROUND: Crohn's disease (CD) is complicated with perianal disease in 21-23% of patients. Presence of perianal disease has been associated with a disabling course of CD and dreadful im...
Introduction:Novel oncolytic agents, including the first-in-class BTKi ibrutinib, have transformed CLL/SLL and MCL treatment. Later-approved BTKis have offered additional treatment choice...